Skip to main content
Premium Trial:

Request an Annual Quote

AnaSpec Licenses Protein Tyrosine Phosphate IP from UW TechTransfer

NEW YORK (GenomeWeb News) – Proteomics products company AnaSpec has licensed intellectual property from the University of Washington’s technology transfer arm, the company said today.
 
AnaSpec has licensed the rights to make, use, and sell protein tyrosine phosphatase substrates covered under UW TechTransfer’s patent No. 5,739,278, entitled “Compositions for Protein Tyrosine Phosphatases.” The San Jose-based company, which sells peptides, detection reagents, and combinatorial chemistry products, said it plans to market the UW protein technology as part of its GO Peptides line.
 
UW TechTransfer manages over 2,000 issued and pending patents filed in the US and abroad, and since its founding in 1982 has been involved in the creation of over 235 companies. 
 
Financial terms of the agreement were not released.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.